Prenetics

Prenetics Global Limited, listed on Nasdaq with the ticker PRE, is a leading health sciences company headquartered in Hong Kong. Founded in 2014, it specializes in preventive healthcare through genomics and digital solutions. Its core operations encompass direct-to-consumer DNA testing via CircleDNA, health and wellness initiatives through IM8, and sports distribution with Europa, empowering individuals with personalized insights and products to enhance well-being.

Prenetics pioneers a Bitcoin treasury strategy in the healthcare sector, designating Bitcoin as a primary reserve asset to diversify its financial portfolio and align with innovative finance. This approach includes active treasury management and plans to accept cryptocurrency payments across its platforms. Beyond treasury, the company integrates blockchain technology into its genomics solutions, bolstering data integrity, privacy, and secure access to health information, fostering a comprehensive digital asset ecosystem.

Led by CEO Danny Yeung and supported by board member Andy Cheung, a cryptocurrency expert, Prenetics holds a prominent industry presence through strategic partnerships, including with David Beckham for IM8. Its fusion of health tech and blockchain positions it as a trailblazer in preventive medicine. By advancing decentralized solutions in healthcare, Prenetics ensures enduring relevance in the global digital health landscape.

Date	BTC Balance	Change (BTC)	Cost Basis	Market Price	Stock Price
Sep 15, 2025	₿228	40.58	$26.3M	—	—
Jun 18, 2025	₿187.42	19,999,963	$19.6M	—	—

Recent Developments